Jun. 26 at 1:44 PM
$AMLX ✅ Healthcare - Mid Cap - Neutral
F-Score: 3/9 🏦
Analysts: 8x buy rating 👨🔬
Potential: Revenue is forecast to grow approximately 73% per year 💠
Range (12m)
$1.62 -
$7.27 💰
RSI: 67.18 (bullish momentum) 📊
NEWSDESK (last recent article) 📰
https://finance.yahoo.com/news/amylyx-pharmaceuticals-gains-fda-fast-164609147.html